Day One Biopharmaceuticals (DAWN) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to -$8.2 million.
- Day One Biopharmaceuticals' Other Gross PP&E Adjustments fell 5079.57% to -$8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.2 million, marking a year-over-year decrease of 5079.57%. This contributed to the annual value of -$6.2 million for FY2024, which is 2053.83% down from last year.
- As of Q3 2025, Day One Biopharmaceuticals' Other Gross PP&E Adjustments stood at -$8.2 million, which was down 5079.57% from -$6.5 million recorded in Q2 2025.
- Day One Biopharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at -$1.2 million for Q1 2022, and its period low was -$8.2 million during Q3 2025.
- In the last 4 years, Day One Biopharmaceuticals' Other Gross PP&E Adjustments had a median value of -$3.8 million in 2024 and averaged -$4.3 million.
- Within the past 5 years, the most significant YoY rise in Day One Biopharmaceuticals' Other Gross PP&E Adjustments was 1614.33% (2023), while the steepest drop was 21545.69% (2023).
- Quarter analysis of 4 years shows Day One Biopharmaceuticals' Other Gross PP&E Adjustments stood at -$2.8 million in 2022, then crashed by 82.72% to -$5.1 million in 2023, then fell by 20.54% to -$6.2 million in 2024, then plummeted by 33.4% to -$8.2 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$8.2 million for Q3 2025, versus -$6.5 million for Q2 2025 and -$7.5 million for Q1 2025.